续骨活血汤治疗踝关节急性骨挫伤的临床疗效观察

Clinical Research on the Efficacy of Xugu Huoxue Decoction in Treating Acute Ankle Bone Contusion

目的:评价续骨活血汤在踝关节急性骨挫伤治疗中的临床疗效。方法:从2019年9月至2022年7月,共收集踝关节急性骨挫伤病例78例,分为2组(各39例),采用不同的治疗方案。治疗组予以续骨活血汤结合踝关节支具固定治疗,同时结合对患者的舌象、脉象等综合分析,进行中医临床辨证分型,随证加减用药。对照组予以地奥司明结合支具固定治疗。连续治疗3个月,采用视觉模拟量表(VAS)评分、美国足踝外科协会(AOFAS)评分及踝关节信号改变区域面积变化作为疗效评价标准。结果:治疗后两组VAS评分、AOFAS评分及踝关节骨挫伤改善率明显优于治疗前,差异有统计学意义(P<0.05);治疗后治疗组VAS评分、AOFAS评分及踝关节骨挫伤改善率明显优于对照组,差异有统计学意义(P<0.05);治疗组不良反应发生率较对照组低,差异有统计学意义(P<0.05)。结论:续骨活血汤可降低VAS评分,提高AOFAS评分,并明显促进局部骨挫伤的水肿吸收,对踝关节急性骨挫伤疗效良好,安全性高,值得临床推广应用。

Objective:To evaluate the clinical efficacy of Xugu Huoxue decoction in treating acute ankle bone contusion.Methods:78 cases of acute ankle bone contusion were selected from September 2019 to July 2022.They were divided into 2 groups according to actual treatment.Patients in treatment group were treated with ankle splint and Xugu Huoxue decoction,who were divided into different subgroups according to tough and pulse and treated with other medicine,while the control group were treated with Diosmin and general supports.All patients were evaluated by score of visual analogue scale(VAS)and American orthopedic foot and ankle society(AOFAS)after 3 months treatment.Results:VAS score and AOFAS score were better after treatment.The difference was of significance(P<0.05).The improvement rate of high signal area was better in treatment group than that in control group after treatment.The difference was of significance(P<0.05).The side efficacy of treatment group was lower than control group,the difference was of significance(P<0.05).Conclusion:Xugu Huoxue decoction can reduce VAS score and raise AOFAS score effectively.It can also reduce the high signal area of ankle in MRI.It has wonderful efficacy on acute ankle bone contusion and has high security,which is worthy of clinical application.